ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 159 filers reported holding ARCELLX INC in Q4 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $212,376,363 | -20.0% | 3,848,095 | +0.8% | 8.13% | -13.1% |
| Q1 2024 | $265,548,507 | +30.8% | 3,818,095 | +4.4% | 9.35% | -1.7% |
| Q4 2023 | $203,053,632 | +91.6% | 3,658,624 | +23.9% | 9.51% | +32.2% |
| Q3 2023 | $105,958,017 | +42.8% | 2,953,122 | +25.8% | 7.19% | +25.4% |
| Q2 2023 | $74,212,140 | +37.0% | 2,347,000 | +33.5% | 5.73% | +11.7% |
| Q1 2023 | $54,157,171 | +98.2% | 1,757,779 | +99.3% | 5.13% | +60.0% |
| Q4 2022 | $27,327,489 | – | 882,101 | – | 3.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 3,146,630 | $174,637,965 | 73.33% |
| NEA Management Company, LLC | 3,745,262 | $207,862,041 | 13.85% |
| Paradigm Biocapital Advisors LP | 3,658,624 | $203,053,632 | 9.51% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,435,974 | $135,196,557 | 6.11% |
| Perceptive Advisors | 4,544,809 | $252,236,900 | 5.63% |
| STEMPOINT CAPITAL LP | 313,604 | $17,405,022 | 4.64% |
| Cormorant Asset Management, LP | 1,700,000 | $94,350,000 | 4.51% |
| Samsara BioCapital, LLC | 460,441 | $25,554,476 | 3.98% |
| Affinity Asset Advisors, LLC | 340,000 | $18,870,000 | 3.45% |
| ACUTA CAPITAL PARTNERS, LLC | 77,000 | $4,273,500 | 2.41% |